Abstract
The penetration of ciprofloxacin into the cerebrospinal fluid (CSF) in 25 patients with non-inflamed meninges and in 9 patients with inflamed meninges was studied. In the patients with non-inflamed meninges plasma and CSF were obtained 1–10 h after the second dose of ciprofloxacin and in the patients with inflamed meninges 1, 2, 3, 5, 7 and 9 h after the second dose. In the first group (non-inflamed meninges) data from 6 patients were obtained 4, 5 and 6 h post-dose. Mean ciprofloxacin concentrations in the CSF ranged from 0.073 mg/l to 0.106 mg/l during this observation time, while in the second group (inflamed meninges) they ranged from 0.089 to 0.260 mg/l. These results demonstrate that ciprofloxacin diffuses into the CSF at concentrations which exceed the MICs ofNeisseria meningitidis and most gram-negative aerobic bacilli.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zeiler HJ, Grohe K: The in vitro and in vivo activity of ciprofloxacin. European Journal of Clinical Microbiology 1984, 3: 339–343.
Bauernfeind A: Antimicrobial activity of ciprofloxacin. In: Neu HC, Weuta H (ed): First International Ciprofloxacin Workshop. Excerpta Medica, Amsterdam, 1986, p. 7–11.
Fass RJ: Comparative in vitro activities of ciprofloxacin β-lactams and aminoglycosides. In: Neu HC, Weuta H (ed): First International Ciprofloxacin Workshop. Excerpta Medica, Amsterdam, 1986, p. 46–49.
LeFrock JL, Smith BR, Molavi A: Gram-negative bacillary meningitis. Medical Clinics of North America 1985, 69: 243–256.
Kitzes-Cohen R, Miler A, Gilboa A, Harel D: Penetration of ciprofloxacin into human cerebrospinal fluid: preliminary results. In: Neu HC, Weuta H (ed): First International Ciprofloxacin Workshop. Excerpta Medica, Amsterdam, 1986, p. 206–207.
Wolff M, Boutron L, Singlas E, Clair B, Decazes JM, Regnier B: Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. Antimicrobial Agents Chemotherapy 1987, 31: 899–902.
Valainis G, Thomas D, Panky G: Penetration of ciprofloxacin into cerebrospinal fluid. European Journal of Clinical Microbiology 1986, 5: 206–208.
Dow J, Frydman AM, Hanny P, Woehrle R, Djeblar F, Gallot J: Transfer kinetics of pefloxacin into cerebrospinal fluid after one hour iv infusion of 400 mg in man. Journal of Antimicrobial Chemotherapy 1986, 17, Supplement: 81–87.
Korinek AM, Montay G, Bianchi A, Guggiari M, Brob R, Viars P: Penetration of pefloxacin into human brain tissue. Reviews of Infectious Diseases 1988, 10: Supplement 1: 257.
Wolff M, Regnier B, Daldoss C, Nkam M, Vachom F: Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis. Antimicrobial Agents and Chemotherapy 1984, 26: 289–291.
Stahl JP, Groize J, Lebfebre MA, Fru A, Leduc D, Foutillan JB, Micoud M: Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis. Infection 1986, 14, Supplement 1: 254–255.
Stubner G, Weirich W, Branch U: Study of cerebrospinal fluid penetrability of ofloxacin. Infection 1986, 14, Supplement 4: 250–253.
Norby SR: 4-quinolones in the treatment of infections of the central nervous system. Reviews of Infectious Diseases 1988, 10, Supplement 1: 253–255.
Rietbrock N, Staib AH: Gyrase-Hemmer: Unerwünschte zentral-nervöse Wirkungen. Deutsche Medizinische Wochenschrift 1987, 112: 201.
Millar MR, Bansby-Zachary MA, Tompkins DS, Hawkey PM, Gibson RM: Ciprofloxacin forPseudomonas aeruginosa meningitis. Lancet 1986, i: 1325.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gogos, C.A., Maraziotis, T.G., Papadakis, N. et al. Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges. Eur. J. Clin. Microbiol. Infect. Dis. 10, 511–514 (1991). https://doi.org/10.1007/BF01963940
Issue Date:
DOI: https://doi.org/10.1007/BF01963940